Reminder - BioSig Subsidiary, ViralClear To Host Conference Call On June 9th To Discuss Upcoming And Recent Developments For Phase II Human Clinical Trials Of Its Broad-Spectrum Oral Anti-Viral Candidate For Treatment Of COVID-19

Press/Media: Expert Comment

PeriodJun 8 2020

Media coverage

11

Media coverage